HGS-ETR2
Term · Oncology and biomedicine · MLC-T-ONC-003873
A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL-R2 on the surface of some tumor cells, which may kill the tumor cells. HGS-ETR2 is a type of monoclonal antibody. Also called anti-TRAIL R2 mAb HGS-ETR2 and lexatumumab.
| Identifier | MLC-T-ONC-003873 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | anti-TRAIL R2 mAb HGS-ETR2; lexatumumab |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003873",
"term": "HGS-ETR2",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL-R2 on the surface of some tumor cells, which may kill the tumor cells. HGS-ETR2 is a type of monoclonal antibody. Also called anti-TRAIL R2 mAb HGS-ETR2 and lexatumumab.",
"expansions": [
"anti-TRAIL R2 mAb HGS-ETR2",
"lexatumumab"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/hgs-etr2/"
}
Record 8,481 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.